US Patent Issued to Harmony Biosciences Management on Feb. 18 for "Treatment of fragile X syndrome with cannabidiol" (North Carolina, Pennsylvania, Minnesota Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,373, issued on Feb. 18, was assigned to Harmony Biosciences Management inc. (Plymouth Meeting, Pa.).

"Treatment of fragile X syndrome with cannabidiol" was invented by Marcel Bonn-Miller (Lexington, N.C.), Nancy Tich (Saint Paul, Minn.), Donna Gutterman (Raleigh, N.C.), John Messenheimer (Moncure, N.C.) and Terri Sebree (Gladwyne, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to a method of treating one or more behavioral symptoms of Fragile X Syndrome in a subject by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein one or more behavioral symptoms of Fragile X Syndrome ar...